Jenna Rychert

Jenna Rychert, PhD

Languages spoken: English

Academic Information

Departments Adjunct - Pathology

Academic Office Information

u6019143@utah.edu

Education History

Postdoctoral Training Harvard Medical School and Massachusetts General Hospital
 Postdoctoral Training
Louisiana State Health Science Center
 PhD
Undergraduate Boise State University
 BS

Selected Publications

Journal Article

  1. Rychert J, Genzen JR (2023). Modifications of FDA-cleared/approved tests. Am J Clin Pathol.
  2. Rychert J, Schmidt RL, Genzen JR (2023). Laboratory-Developed Tests Account for a Small Minority of Tests Ordered in an Academic Hospital System. Am J Clin Pathol.
  3. Genzen JR, Rychert J, George TI (2022). Integrity of SARS-CoV-2 Laboratory-Developed Tests. JAMA, 328(5), 478.
  4. Nandakumar V, Profaizer T, Lozier BK, Elgort MG, Rychert J, Slev PR, Delgado JC (2021). Evaluation of a Novel Multiplex Platform for Simultaneous Detection of IgG Antibodies Against the 4 Main SARS-CoV-2 Antigens. J Appl Lab Med, 7(3), 698-710.
  5. Nandakumar V, Profaizer T, Lozier BK, Elgort MG, Larragoite ET, Williams ESCP, Solis-Leal A, Lopez JB, Berges BK, Planelles V, Rychert J, Slev PR, Delgado JC (2021). Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays. Arch Pathol Lab Med, 145(10), 1212-1220.
  6. Rychert J, Couturier MR, Elgort M, Lozier BK, Laulu S, Genzen JR, Straseski JA, Delgado JC, Slev PR (2020). Evaluation of 3 SARS-CoV-2 IgG Antibody Assays and Correlation with Neutralizing Antibodies. J Appl Lab Med, 6(3), 614-624.
  7. Zheng Y, Larragoite ET, Williams ESCP, Lama J, Cisneros I, Delgado JC, Slev P, Rychert J, Innis EA, Coiras M, Rondina MT, Spivak AM, Planelles V (2021). Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions. Virol J, 18(1), 1.
  8. Rychert J, Delgado JC, Genzen JR (2020). Modification of In Vitro Diagnostic Devices: Leveling the Playing Field. Clin Chem, 66(6), 760-762.
  9. Body BA, Beard MA, Slechta ES, Hanson KE, Barker AP, Babady NE, McMillen T, Tang YW, Brown-Elliott BA, Iakhiaeva E, Vasireddy R, Vasireddy S, Smith T, Wallace RJ Jr, Turner S, Curtis L, Butler-Wu S, Rychert J (2018). Evaluation of the Vitek MS v3.0 Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry System for Identification of Mycobacterium and Nocardia Species. J Clin Microbiol, 56(6).
  10. Rychert J, Slechta ES, Barker AP, Miranda E, Babady NE, Tang YW, Gibas C, Wiederhold N, Sutton D, Hanson KE (2018). Multicenter Evaluation of the Vitek MS v3.0 System for the Identification of Filamentous Fungi. J Clin Microbiol, 56(2).
  11. Schlaberg R, Barrett A, Edes K, Graves M, Paul L, Rychert J, Lopansri BK, Leung DT (2018). Fecal Host Transcriptomics for Non-Invasive Human Mucosal Immune Profiling: Proof of Concept in Clostridium Difficile Infection. Pathog Immun, 3(2), 164-180.
  12. Wesolowski LG, Nasrullah M, Coombs RW, Rosenberg E, Ethridge SF, Hutchinson AB, Dragavon J, Rychert J, Nolte FS, Madory JE, Werner BG (2015). Acute Infections, Cost per Infection and Turnaround Time in Three United States Hospital Laboratories Using Fourth-Generation Antigen-Antibody Human Immunodeficiency Virus Immunoassays. Open Forum Infect Dis, 3(1), ofv188.
  13. Ivers LC, Charles RC, Hilaire IJ, Mayo-Smith LM, Teng JE, Jerome JG, Rychert J, LaRocque RC, Xu P, Kovc P, Ryan ET, Qadri F, Almazor CP, Franke MF, Harris JB (2015). Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection. J Infect Dis, 212(5), 779-83.
  14. Harrington SM, Buchan BW, Doern C, Fader R, Ferraro MJ, Pillai DR, Rychert J, Doyle L, Lainesse A, Karchmer T, Mortensen JE (2015). Multicenter evaluation of the BD max enteric bacterial panel PCR assay for rapid detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga toxin 1 and 2 genes. J Clin Microbiol, 53(5), 1639-47.
  15. Rychert J, Creely D, Mayo-Smith LM, Calderwood SB, Ivers LC, Ryan ET, Boncy J, Qadri F, Ahmed D, Ferraro MJ, Harris JB (2014). Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Vibrio cholerae. J Clin Microbiol, 53(1), 329-31.
  16. Rychert J, Danziger-Isakov L, Yen-Lieberman B, Storch G, Buller R, Sweet SC, Mehta AK, Cheeseman JA, Heeger P, Rosenberg ES, Fishman JA (2014). Multicenter comparison of laboratory performance in cytomegalovirus and Epstein-Barr virus viral load testing using international standards. Clin Transplant, 28(12), 1416-23.
  17. Vaidya SA, Korner C, Sirignano MN, Amero M, Bazner S, Rychert J, Allen TM, Rosenberg ES, Bosch RJ, Altfeld M (2014). Tumor necrosis factor α is associated with viral control and early disease progression in patients with HIV type 1 infection. J Infect Dis, 210(7), 1042-6.
  18. Garner O, Mochon A, Branda J, Burnham CA, Bythrow M, Ferraro M, Ginocchio C, Jennemann R, Manji R, Procop GW, Richter S, Rychert J, Sercia L, Westblade L, Lewinski M (2013). Multi-centre evaluation of mass spectrometric identification of anaerobic bacteria using the VITEK® MS system. Clin Microbiol Infect, 20(4), 335-9.
  19. Manji R, Bythrow M, Branda JA, Burnham CA, Ferraro MJ, Garner OB, Jennemann R, Lewinski MA, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Westblade LF, Ginocchio CC (2013). Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli. Eur J Clin Microbiol Infect Dis, 33(3), 337-46.
  20. Branda JA, Rychert J, Burnham CA, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Sercia LF, Westblade LF, Ferraro MJ (2013). Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria. Diagn Microbiol Infect Dis, 78(2), 129-31.
  21. Richter SS, Sercia L, Branda JA, Burnham CA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Rychert JA, Westblade LF, Procop GW (2013). Identification of Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using the VITEK MS system. Eur J Clin Microbiol Infect Dis, 32(12), 1571-8.
  22. Vaidya SA, Streeck H, Beckwith N, Ghebremichael M, Pereyra F, Kwon DS, Addo MM, Rychert J, Routy JP, Jessen H, Kelleher AD, Hecht F, Sekaly RP, Carrington M, Walker BD, Allen TM, Rosenberg ES, Altfeld M (2013). Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection. Retrovirology, 10, 139.
  23. Branda JA, Markham RP, Garner CD, Rychert JA, Ferraro MJ (2013). Performance of the Vitek MS v2.0 system in distinguishing Streptococcus pneumoniae from nonpneumococcal species of the Streptococcus mitis group. J Clin Microbiol, 51(9), 3079-82.
  24. Rychert J, Burnham CA, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Sercia L, Westblade LF, Ferraro MJ, Branda JA (2013). Multicenter evaluation of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Gram-positive aerobic bacteria. J Clin Microbiol, 51(7), 2225-31.
  25. Westblade LF, Jennemann R, Branda JA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Burnham CA (2013). Multicenter study evaluating the Vitek MS system for identification of medically important yeasts. J Clin Microbiol, 51(7), 2267-72.
  26. Rychert J, Jones L, McGrath G, Bazner S, Rosenberg ES (2013). A monoclonal antibody against lymphocyte function-associated antigen-1 decreases HIV-1 replication by inducing the secretion of an antiviral soluble factor. Virol J, 10, 120.
  27. Li C, Toth I, Schulze Zur Wiesch J, Pereyra F, Rychert J, Rosenberg ES, van Lunzen J, Lichterfeld M, Yu XG (2013). Functional characterization of HLA-G⁺ regulatory T cells in HIV-1 infection. PLoS Pathog, 9(1), e1003140.
  28. Soghoian DZ, Jessen H, Flanders M, Sierra-Davidson K, Cutler S, Pertel T, Ranasinghe S, Lindqvist M, Davis I, Lane K, Rychert J, Rosenberg ES, Piechocka-Trocha A, Brass AL, Brenchley JM, Walker BD, Streeck H (2012). HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med, 4(123), 123ra25.
  29. Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power KA, Macalalad AR, Berlin AM, Malboeuf CM, Ryan EM, Gnerre S, Zody MC, Erlich RL, Green LM, Berical A, Wang Y, Casali M, Streeck H, Bloom AK, Dudek T, Tully D, Newman R, Axten KL, Gladden AD, Battis L, Kemper M, Zeng Q, Shea TP, Gujja S, Zedlack C, Gasser O, Brander C, Hess C, Gnthard HF, Brumme ZL, Brumme CJ, Bazner S, Rychert J, Tinsley JP, Mayer KH, Rosenberg E, Pereyra F, Levin JZ, Young SK, Jessen H, Altfeld M, Birren BW, Walker BD, Allen TM (2012). Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog, 8(3), e1002529.
  30. Huang J, Yang Y, Al-Mozaini M, Burke PS, Beamon J, Carrington MF, Seiss K, Rychert J, Rosenberg ES, Lichterfeld M, Yu XG (2011). Dendritic cell dysfunction during primary HIV-1 infection. J Infect Dis, 204(10), 1557-62.
  31. Vigneault F, Woods M, Buzon MJ, Li C, Pereyra F, Crosby SD, Rychert J, Church G, Martinez-Picado J, Rosenberg ES, Telenti A, Yu XG, Lichterfeld M (2010). Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J Virol, 85(6), 3015-9.
  32. Chevalier MF, Jlg B, Pyo A, Flanders M, Ranasinghe S, Soghoian DZ, Kwon DS, Rychert J, Lian J, Muller MI, Cutler S, McAndrew E, Jessen H, Pereyra F, Rosenberg ES, Altfeld M, Walker BD, Streeck H (2010). HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J Virol, 85(2), 733-41.
  33. Rychert J, Strick D, Bazner S, Robinson J, Rosenberg E (2010). Detection of HIV gp120 in plasma during early HIV infection is associated with increased proinflammatory and immunoregulatory cytokines. AIDS Res Hum Retroviruses, 26(10), 1139-45.
  34. Rychert J, Saindon S, Placek S, Daskalakis D, Rosenberg E (2008). Sequence variation occurs in CD4 epitopes during early HIV infection. J Acquir Immune Defic Syndr, 46(3), 261-7.
  35. Rychert J, Lacour N, Amedee AM (2006). Genetic analysis of simian immunodeficiency virus expressed in milk and selectively transmitted through breastfeeding. J Virol, 80(8), 3721-31.
  36. Rychert J, Amedee AM (2005). The antibody response to SIV in lactating rhesus macaques. J Acquir Immune Defic Syndr, 38(2), 135-41.
  37. Amedee AM, Rychert J, Lacour N, Fresh L, Ratterree M (2004). Viral and immunological factors associated with breast milk transmission of SIV in rhesus macaques. Retrovirology, 1, 17.

Review

  1. Rychert J (2023). In support of interoperability: A laboratory perspective. [Review]. Int J Lab Hematol, 45(4), 436-441.
  2. Christensen RE, Yi MD, Kang BY, Ibrahim SA, Anvery N, Dirr M, Adams S, Amer YS, Bisdorff A, Bradfield L, Brown S, Earley A, Fatheree LA, Fayoux P, Getchius T, Ginex P, Graham A, Green CR, Gresele P, Hanson H, Haynes N, Hegeds L, Hussein H, Jakhmola P, Kantorova L, Krishnasamy R, Krist A, Landry G, Lease ED, Ley L, Marsden G, Meek T, Meremikwu M, Moga C, Mokrane S, Mujoomdar A, Newton S, OFlynn N, Perkins GD, Smith EJ, Prematunge C, Rychert J, Saraco M, Schnemann HJ, Senerth E, Sinclair A, Shwayder J, Stec C, Tanni S, Taske N, Temple-Smolkin RL, Thomas L, Thomas S, Tonnessen B, Turner AS, Van Dam A, van Doormaal M, Wan YL, Ventura CB, McFarlane E, Morgan RL, Ogunremi T, Alam M (2023). Development of an international glossary for clinical guidelines collaboration. [Review]. J Clin Epidemiol, 158, 84-91.

Letter

  1. Westblade LF, Jennemann R, Branda JA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Burnham CA (2013). Reply to "risks of 'blind' automated identification systems in medical microbiology". [Letter to the editor]. J Clin Microbiol, 51(11), 3912.